US to ask if Sanofi antibiotic Ketek should still be sold
U.S. health officials said they plan to ask outside advisers in December 2006 if the antibiotic Ketek manufactured by Sanofi-Aventis should stay on the market after a dozen reports of liver failure. (Source)